JPND announces €30 million call for neurodegenerative disease research

JPND, the EU's neurodegenerative disease research initiative, has announced a €30 million call for multinational research on personalised medicine for neurodegenerative diseases. 

Neurodegenerative diseases are debilitating and still largely untreatable. One of the biggest challenges is the large variability in their origins, mechanisms and clinical expression, requesting treatments that will need to take into account all these specificities.

JPND is therefore seeking proposals from multinational research teams for ambitious, innovative and multidisciplinary collaborative research projects to change the trajectory of these diseases through the development of precision medicine approaches.

Professor Thomas Gasser, University of Tübingen (Germany) and Chair of the JPND Scientific Advisory Board said: "Progresses in precision medicine will be a unique way to develop innovative approaches to prevent, slow and cure neurodegenerative diseases. This call aims to harness the necessary expertise across Europe and globally, to address this research challenge."

The call covers several diseases including Alzheimer’s and other dementias, Parkinson’s disease and PD-related disorders, Prion diseases, Motor Neuron diseases, Hungtington’s disease, Spinocerebellar ataxia and Spinal muscular atrophy. Proposals must tackle diagnosis, prevention or care. 

JPND is the largest global research initiative aimed at tackling the challenge of neurodegenerative diseases.